<div id="readability-page-1"><p>Roth MKM analyst Kyle Bauser reiterated a Buy rating on HeartBeam today and set a price target of $4.00.</p><h3>TipRanks Cyber Monday Sale</h3><ul><li> Claim 60% off TipRanks Premium  for data-backed insights and research tools you need to invest with confidence.  </li><li>  Subscribe to TipRanks' Smart Investor Picks  and see our data in action through our high-performing model portfolio - <u> now also 60% off </u></li></ul> <p>Bauser covers the Healthcare sector, focusing on stocks such as Sanuwave Health, HeartBeam, and Electromed. According to TipRanks, Bauser has an average return of <span>-11.9%</span> and a 38.03% success rate on recommended stocks. </p> <p>The word on The Street in general, suggests a Strong Buy analyst consensus rating for HeartBeam with a $4.83 average price target.</p></div>

BEAT

<p>Roth MKM analyst Kyle Bauser reiterated a Buy rating on HeartBeam with a price target of $4.00. Bauser covers the Healthcare sector and has an average return of -11.9% with a 38.03% success rate. The analyst consensus for HeartBeam is a Strong Buy with a $4.83 average price target.</p>

Roth MKM Reaffirms Their Buy Rating on HeartBeam (BEAT)